Data / Form D filings / Dermata Therapeutics, Inc.
Dermata Therapeutics, Inc.: Form D filing
Dermata Therapeutics, Inc., a biotechnology company in San Diego, CA, filed a Form D with the SEC in 2026. The latest, on January 7, 2026, reports $4.1 million sold of a $4.1 million offering to 14 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3525 DEL MAR HEIGHTS RD. #322, San Diego, CA, 92130
- Phone
- (858) 223-0882
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1853816
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 7 | New notice | $4,124,591 | $4,124,591 | 14 | Dec 29 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gerald Proehl | Executive Officer, Director | |
| Kyri K. Van Hoose | Executive Officer | |
| Christopher J. Nardo | Executive Officer | |
| Maria Bedoya Toro Munera | Executive Officer | |
| David Hale | Director | |
| Wendell Wierenga | Director | |
| Andrew Sandler | Director | |
| Brittany Bradrick | Director | |
| Kathleen Scott | Director | |
| Mary Fisher | Director | |
| Steven J. Mento | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $22.9 million · Oct 21
- Theravie Pharma, Inc. $750,000 · Oct 19
- Adela, Inc. $12 million · Oct 19
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16
- Renue Life Sciences, Inc. $250,000 · Oct 14
- Tempest Therapeutics, Inc. $7.5 million · Oct 14
Every Form D from the week of Jan 5 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Dermata Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.